1108 J. Chin. Chem. Soc., Vol. 49, No. 6, 2002
Chen et al.
1
flavone (4) with a yield of 32.0%, m.p. 98-9 C. H NMR
(CDCl3, 500 MHz): 6.84 (s, 1H), 7.41-7.43 (m, 1H), 7.53-
7.60 (m, 4H), 7.69-7.71 (m, 1H), 7.93-7.96 (m, 1H), 8.23-
8.26 (m, 1H); 13C NMR (CDCl3, 125 MHz): 107.62, 118.09,
123.97, 125.24, 125.72, 126.31, 129.05, 131.61, 131.80,
133.78, 156.27, 163.42, 178.49; MS (EI, m/z, %): 92 (75.7),
120 (96.8), 165 (13.0), 194 (45.3), 222 (M, 100); MS (FAB,
m/z, %): 136 (89.4), 154 (100), 233 (M+1, 40.3); Anal.:
Found: C:81.06%, H: 4.63%; Calcd. for C15H10O2: C:
81.07%, H: 4.54%.
NMR (CDCl3, 500 MHz): 2.86-2.90 (m, 1H), 3.05-3.11 (m,
1H), 5.46-5.49 (m, 1H), 7.03-7.06 (m, 2H), 7.37-7.50 (m,
6H), 7.9-7.93 (m, 1H); 13C NMR (CDCl3, 125 MHz): 30.91,
44.66, 79.59, 118.12, 121.61, 126.13, 127.03, 128.77,
128.84, 136.20, 207.01; MS (EI, m/z, %): 92 (85.0), 104
(44.7), 120 (100), 121 (22.9), 147 (45.3), 223 (21.7), 224 (M,
24.8), 225 (M+1, 3.1); HRMS: 224.0834 (M+), calcd.
224.0837.
ACKNOWLEDGEMENT
Typical Anodic Dimerization of Flavone (4)
Cathodic dimerization of flavone (4) was carried out in
a 40 mL H-type cell with a glass-filter diaphragm equipped
with a Pb-plat (2 2 cm) as a cathode and a graphite rod (di-
ameter: 0.7 cm) as an anode. The cathode compartment con-
tained a solution of flavone (4) (100.0 mg, 0.35 mmol) in 2
mL of metha n o l with sulfuric acid (0.1 mL, 0.1 M) used as
supporting electrolytes. The anode compartment contained a
solution of 20 mL of methanol with sulfuric acid (0.1 mL, 0.1
M) used as supporting electrolytes. After 7 F/mol of electric-
ity was passed with constant current of 10 mA und e r the con-
dition of external cooling (0 C), the cathode solution was
evaporated to remove the solvent under a reduced pressure.
The residue was dissolved in ethyl ether and was washed with
saturated aqueous sodium bicarbonate and saturated brine.
The organic layer was dried over sodium sulfate and evapo -
rated to remove the solvent. The residue was chromato-
graphed on silica gel and was eluted with benzene to give
three white crystals: 2,2 -biflavanone(recemate) (5a) (32.5
mg, 0.07 mmol, 32.4%, m.p. 212-5 C), 2,2 -biflavanone
(meso) (5b) (24.9 mg, 0.06 mmol, 24.8%, m.p. 288-290 C)
and flavone (6) (2.3 mg, 2.0%, m.p. 77-80 C); 2,2 -biflavan-
one(recemate) (5a): 1H NMR (CDCl3, 500 MHz): 3.35 (d,
2H, J = 16.5 Hz), 3.96 (d, 2H, J = 16.5 Hz), 6.91-6.94 (m,
4H), 7.08-7.18 (m, 10H), 7.50-7.47 (m, 2H), 7.67-7.65 (m,
2H); 13C NMR (CDCl3, 125 MHz): 41.02, 87.96, 118.23,
121.40, 121.47, 126.48, 127.74, 128.61, 128.84, 135.00,
136.18, 159.27, 191.24; MS (EI, m/z, %): 92 (16.1), 103
(14.9), 121 (54.6), 223 (M/2, 100), 224 (M/2+1, 14.2);
HRMS: 446.1515 (M+), calcd. 446.1518; 2,2 -biflavanone
(meso) (5b): 1H NMR (CDCl3, 500 MHz): 3.12 (d, 2H, J =
16.0 Hz), 3.65 (d, 2H, J = 16.0 Hz), 6.88-6.91 (m, 2H). 7.12
(d, 2H, J = 8.0 Hz), 7.22-7.39 (m, 8H), 7.39 (d, 2H, J = 6.5
Hz), 7.46-7.49 (m, 2H), 7.58-7.60 (m, 2H); 13C NMR (CDCl3,
125 MHz): 42.42, 87.11, 117.94, 121.34, 121.50, 126.50,
128.10, 128.48, 129.09, 135.91, 126.22, 158.76, 190.50; MS
(EI, m/z, %): 121 (14.2), 223 (M/2, 100), 224 (M/2+1, 14.2);
HRMS: 446.1517 (M+), calcd. 446.1518; flavanone (6): 1H
This study was financially supported by the National
Science Council of the Republic of China (NSC89-2113-M -
017-001).
Received March 28, 2002.
Key Words
Flavone; Flavanone; Biflavanones; Electrolytic
reductive coupling; Hydrodimerization.
REFERENCES
1. (a) Harborne, J. B.; Mabry, T. J. The Flavonoids: Advances
in Reseach; Chapman and Hall: New York, 1982; pp
505-533. (b) Ferreira, D.; Steynberg, J. P.; Roux, D. G.;
Brandt, E. V. Tetrahedron 1992, 48, 1743.
2. (a) Horhammer, L.; Wagner, H.; Reinharht, H. Z. Natur-
forsch 1967, 22B, 768. (b) Natarajan, S.; Murti, V. V. S.;
Seshadri, T. R.; Ramaswami, A. S. Curr. Sci. 1970, 39, 533.
(c) Ruckstuhl, M.; Beretz, W. B.; Anton, R.; Land r y, Y.
Biochem. Pharmacol. 1979, 28, 535. (d) Beretz, A.; Joly, N.;
Stochet, J. C.; Anton, R. Planta. Med. 1979, 36, 193. (e)
Joly, M.; Beck, J. P.; Haag-Berrcuier, M.; Anton, R. Planta.
Med. 1980, 39, 230.
3. (a) Lee, S. L.; Choi, J. H.; Son, K. H.; Chang, H. W.; Kong, S.
S.; Kim, H. p. Life Sci. 1995, 57, 551. (b) Lee, H. S.; Ko, H.
R.; Ryu, S. Y.; Oh, W. K.; Kim, B. Y.; Ahn, S. C.; Mheen, T.
I.; Ahn, J. S. Planta Med. 1997, 63, 266. (c) Gil, B.; Sanz, M.
J.; Terencio, M. C.; Gunasegaran, R.; Paya, M.; Alcaraz, M.
J. Biochem. Pharmacol. 1997, 53, 733. (d) Lin, Y. M.; An-
derson, H.; Flavin, M. T.; Pai, Y. H. J. Nat. Prod. 1997, 60,
884. (e) Vlietinck, A. J.; Breuyne, T. D.; Apers, S.; Pieters, L.
A. Planta Med. 1998, 64, 97. (f) Cimanga, K.; Bruyne, T. D.;
Aper, S.; Pireters, L.; Totte, J.; Kambu, K.; Tona, L.; Bakana,
P.; Ufford, L. Q.; Beukelman, C.; Labadie, R.; Vlietinok, A.
J. Planta Med. 1999, 65, 213. (g) Lin, Y. M.; Flavin, M. T.;
Schure, R.; Chen, F. C.; Sidwell, R.; Barnard, D. L. Planta